Literature DB >> 23608718

Testing the feasibility of therapeutic identification of depression in young people in British general practice.

Tami Kramer1, Steve Iliffe, Amanda Bye, Lisa Miller, Julia Gledhill, M Elena Garralda.   

Abstract

PURPOSE: Depression in young people attending primary care is common and is associated with impairment and recurrence into adulthood. However, it remains under-recognized. This study evaluated the feasibility of training primary care practitioners (PCPs) in screening and therapeutic identification of adolescent depression, and assessed its effects on practitioner knowledge, attitudes, screening, and management.
METHODS: We trained PCPs in therapeutic identification of adolescent depression during general practice consultations. To assess changes in knowledge and attitudes, PCPs completed questionnaires before and after training. We ascertained changes in depression screening and identification rates in the 16 weeks before and after training from electronic medical records of young people aged 13-17 years. Post-training management of depression was recorded on a checklist.
RESULTS: Aspects of practitioner knowledge (of depression prevalence and treatment guidelines) and confidence (regarding depression identification and management) increased significantly (all p < .04). Overall screening rates were enhanced from .7% to 20% after the intervention and depression identification rates from .5% before training to 2% thereafter (29-fold and fourfold increases, respectively). Identification was significantly associated with PCP knowledge of prior mental health problems (Fisher's exact test, p = .026; odds ratio, 4.884 [95% confidence interval, 1.171-20.52]) and of psychosocial stressors (Fisher's exact test, p = .001; odds ratio, 17.45 [95% confidence interval, 2.055-148.2]).
CONCLUSIONS: The Therapeutic Identification of Depression in Young People program is a feasible approach to improving primary care screening for adolescent depression, with promising evidence of effectiveness. Further evaluation in a randomized trial is required to test practitioner accuracy, clinical impact, and cost benefit.
Copyright © 2013 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23608718     DOI: 10.1016/j.jadohealth.2012.12.017

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  6 in total

Review 1.  Educational interventions: equipping general practice for youth mental health and substance abuse. A discussion paper.

Authors:  A O'Regan; E Schaffalitzky; W Cullen
Journal:  Ir J Med Sci       Date:  2015-04-16       Impact factor: 1.568

2.  Development and implementation of a 'Mental Health Finder' software tool within an electronic medical record system.

Authors:  D Swan; A Hannigan; S Higgins; R McDonnell; D Meagher; W Cullen
Journal:  Ir J Med Sci       Date:  2017-01-03       Impact factor: 1.568

3.  Child and adolescent psychiatry: which knowledge and skills do primary care physicians need to have? A survey in general practitioners and paediatricians.

Authors:  Thomas Lempp; Monika Heinzel-Gutenbrunner; Christian Bachmann
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-08-07       Impact factor: 4.785

4.  Service use in adolescents at risk of depression and self-harm: prospective longitudinal study.

Authors:  Kapil Sayal; Nichola Yates; Melissa Spears; Paul Stallard
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-26       Impact factor: 4.328

5.  Recent trends in primary-care antidepressant prescribing to children and young people: an e-cohort study.

Authors:  A John; A L Marchant; D L Fone; J I McGregor; M S Dennis; J O A Tan; K Lloyd
Journal:  Psychol Med       Date:  2016-12       Impact factor: 7.723

6.  Detecting young people with mental disorders: a cluster-randomised trial of multidisciplinary health teams at the GP office.

Authors:  Ole Rikard Haavet; Jūratė Šaltytė Benth; Svein Gjelstad; Ketil Hanssen-Bauer; Mina Piiksi Dahli; Nick Kates; Torleif Ruud
Journal:  BMJ Open       Date:  2021-12-24       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.